Skip to main content

Table 2 Types of data commonly used in ML-dementia

From: Understanding machine learning applications in dementia research and clinical practice: a review for biomedical scientists and clinicians

Input data Categories

Assessments/Techniques

Cost

Invasiveness

Targets

Datasetsb

Biopsy

Brain tissue biopsy

AU$1,601.8a

High

Amyloid plaques, neurofibrillary tangles, etc

-

Blood/CSF biomarker

Lumbar puncture

AU $109a

High

CSF-Aβ & CSF-tau [23], neurofilament light chain, etc

2, 3, 4, 5, 6, 7, 8, 9, 11, 17

Blood testing (e.g., HRMS [24])

US$200—$500 [25]

Minimum

Neurofilament light chain; plasma Aβ42/Aβ40 [26], p-tau 181, p-tau231, and p-tau217 [27], etc

2, 3, 5, 8, 9,15, 16

Omics (blood/serum, urine, saliva)

Genomics

US$990 for Alzheimer’s disease, familial, plus APOE panel [28]

None/minimum

APP, APOE, PSEN1, PSEN2, etc

1, 2, 3, 4, 5,7, 10, 15

Metabolomics

US$100—US$500 [29]

None/minimum

Amino acids, carbohydrates, fatty acids, etc

2, 4, 7,8, 10, 15

Proteomics

$132 [30]

None/minimum

GFAP [31] and LTBP2 [32] etc

2, 4, 8, 15

Transcriptomics

AU$200 [33]

None/minimum

MicroRNAs, mRNA levels, etc

2, 5, 10, 15

Cognitive assessments

Neuropsychological evaluation

Vary by healthcare system

None

ADAS-Cog, CDR, MMSE, etc

3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 17

Questionnaire

Labor cost

None

ECOG and FAQ, etc

Demographics or clinical data from EHR

Census, observational cohort study, clinical history

Labor cost

None

Age, economic status, education, gender, lifestyle, medical history, race, etc

1, 2, 3, 4, 5, 6,7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17

Imaging

DTI

US$97 [34]

None

White matter integrity, brain network connectivity, etc.

3, 6, 7, 11

Retinal imaging

AU$55a

None

Network complexity, tortuosity, vessel calibers, etc

14

CT

AU$342.95a

None

Structural images

1

MRI

AU$426.5a

None

Functional MRI: tracking alterations in blood flow linked to neural activity [35]

structural MRI: brain anatomy images [36]

3, 4, 6, 8, 11, 15, 17

PET

AU$605.05a

None/moderate

Aβ-PET, FDG-PET, tau-PET [37], etc

2, 6, 7, 8, 9, 11, 17

Physiological monitoring

EEG

AU$358.45a

None

Brain waves, electrical activity of the brain, etc

1, 17

ECG

AU$167.55a

None

Electrical activity of the heart, etc

1, 2, 10, 17

Speech and language [38]

Microphones & recording

-

None

Acoustic, prosodic, etc

-

  1. Abbreviations: Aβ amyloid-beta, ADAS-Cog Alzheimer's Disease Assessment Scale—Cognitive Subscale, APOE apolipoprotein E, APP amyloid precursor protein, CDR Clinical Dementia Rating, CSF cerebrospinal fluid, CT computed tomography, DTI diffusion tensor image, ECG electrocardiogram, ECOG Everyday Cognition Scale, EEG electroencephalogram, EHR electronic health records, FAQ Functional Activities Questionnaire, FDG-PET fluorodeoxyglucose positron emission tomography, GDF15 growth differentiation factor 15, GFAP glial fibrillary acidic protein, HMRS high-resolution mass spectrometry, LTBP2 latent transforming growth factor beta binding protein 2, MMSE Mini-Mental State Examination, MRI magnetic resonance imaging, PSEN1 presenilin 1, PSEN2 presenilin 2, PET positron emission tomography
  2. aprices were obtained from Australia Medicare Benefits Schedule website in June 2024 [39]
  3. brefer to Table 1 for dataset number